Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers

cnbc.com/2025/10/16/genentech-launches-direct-to-consumer-program-for-flu-pill-xofluza.html

The program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current list price before insurance.

This story appeared on cnbc.com, 2025-10-16 16:08:00.
The Entire Business World on a Single Page. Free to Use →